This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Vision Expo 2024 – Stand 13
Next generation gene therapy
About our research
Our team is using the latest genetic and nanoparticle technology to develop new therapies to treat incurable inherited retinal diseases (IRDs) as well as longer lasting, less invasive treatments for more common, chronic eye conditions.
What you’ll see
We’ll show you how we apply advanced gene technology to create less invasive and more effective treatments for vision loss.
Talk to us about
- How can emerging genetic technologies, such as gene editing, be used to treat eye diseases?
- Can we tailor gene therapy to achieve a safe and effective treatment to prevent vision loss?
- Could eye drops one day reduce the need for regular anti-VGEF injections for neovascular eye diseases?